Toray aims to perk up business with advanced car materials

Toray aims to perk up business with advanced car materials

NAGOYA, Japan - Toray Industries Inc. opened to the public its new research and development center for automobile and aircraft materials, called Automotive Center, in Nagoya, on Oct. 1. Toray aims to bolster its business by delivering light and eco-friendly materials to meet the needs of carmakers. (Kyodo)

  • Product Code
  • ILEA000040147
  • Registered date
  • 2008/10/01 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1737 × 1303 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 596.90(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Rapidus R&D hub in northern Japan

    Rapidus R&D hub in northern Japan

    Photo taken on Oct. 3, 2024, shows a space earmarked for a research and development center of chipmaker Rapidus Corp. inside printer manufacturer Seiko Epson Corp.'s plant in Chitose, Hokkaido, northern Japan. A ceremony marking the start of construction was held the same day, with the research center expected to begin operating in April 2026.
      Rapidus R&D hub in northern Japan

      Rapidus R&D hub in northern Japan

      Yasunori Ogawa (L), president of printer manufacturer Seiko Epson Corp., and Atsuyoshi Koike, his counterpart of chipmaker Rapidus Corp., pose for a photo during a press conference in Chitose, Hokkaido, northern Japan, on Oct. 3, 2024. The two companies have agreed to the building of a Rapidus research and development center in Seiko Epson's plant in Chitose, with the facility expected to begin operating in April 2026.
        Rapidus R&D hub in northern Japan

        Rapidus R&D hub in northern Japan

        Photo taken on Oct. 3, 2024, shows printer manufacturer Seiko Epson Corp.'s plant in Chitose, Hokkaido, northern Japan, in which a research and development center of chipmaker Rapidus Corp. will be housed. A ceremony marking the start of construction was held the same day, with the research center expected to begin operating in April 2026.

          Mitsubishi Motors to join Nissan-Honda alliance for EV development

          TOKYO, Japan, Aug. 1 Kyodo - Nissan Motor Co. President Makoto Uchida and Honda Motor Co. President Toshihiro Mibe attend a joint press conference in Tokyo on Aug. 1, 2024, to announce that Mitsubishi Motors Corp. will join a strategic partnership formed between the two carmakers to develop electric vehicles in a bid to catch up with powerful overseas rivals. (Kyodo)
            Banking Institution And Luxury Brands

            Banking Institution And Luxury Brands

            ZRICH, SWITZERLAND - NOVEMBER 13: The Mitsubishi Motors Corporation logo, the Japanese multinational automobile manufacturer headquartered in Tokyo, captured in one of its shops in Zrich on November 13, 2023, in Zrich, Switzerland. (Photo by Joan Cros/NurPhoto)
              Mitsubishi Aircraft to scale down passenger jet development operation

              Mitsubishi Aircraft to scale down passenger jet development operation

              File photo taken on March 18, 2020, shows a new prototype of Mitsubishi Aircraft Corp.'s SpaceJet passenger jet at Nagoya airport in Aichi Prefecture, central Japan. Mitsubishi Aircraft said June 15, 2020, that it will downsize and reshuffle the team developing Japan's first passenger jet in the face of plunging air travel demand due to the new coronavirus pandemic, in a move that could further delay the aircraft's launch. (Kyodo) ==Kyodo
                Mitsubishi Aircraft to scale down passenger jet development operation

                Mitsubishi Aircraft to scale down passenger jet development operation

                File photo taken on March 18, 2020, shows a new prototype of Mitsubishi Aircraft Corp.'s SpaceJet passenger jet at Nagoya airport in Aichi Prefecture, central Japan. Mitsubishi Aircraft said June 15, 2020, that it will downsize and reshuffle the team developing Japan's first passenger jet in the face of plunging air travel demand due to the new coronavirus pandemic, in a move that could further delay the aircraft's launch. (Kyodo) ==Kyodo
                  Mitsubishi Aircraft to scale down passenger jet development operation

                  Mitsubishi Aircraft to scale down passenger jet development operation

                  File photo taken in March 2020 shows a new prototype of Mitsubishi Aircraft Corp.'s SpaceJet passenger jet at Nagoya airport in Aichi Prefecture, central Japan. Mitsubishi Aircraft said June 15, 2020, that it will downsize and reshuffle the team developing Japan's first passenger jet in the face of plunging air travel demand due to the new coronavirus pandemic, in a move that could further delay the aircraft's launch. (Kyodo) ==Kyodo
                    Shionogi's new mid-term management plan briefing

                    Shionogi's new mid-term management plan briefing

                    On the 1st, Shionogi announced a new mid-term management plan to invest 500 billion yen in expanding overseas business and launching new businesses by FY2024. The company will also increase research and development expenses by 20% over the past five years to about 342.1 billion yen. In addition to strengthening its own sales of pharmaceuticals in Japan and overseas, the company will also invest heavily in products and services other than ethical drugs, such as vaccines.In terms of sales strategy, the company plans to strengthen its sales in the U.S. and China, and increase the ratio of overseas sales to more than 50% in FY2012 (18.5% in FY2007). President Tedairogi said, "We aim to become a drug discovery company that people from outside the company want to work with," and also indicated that the company will place importance on alliance strategies. (Photo taken on June 1, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                      KM Biologics begins development of vaccine for novel coronavirus

                      KM Biologics begins development of vaccine for novel coronavirus

                      KM Biologics (Kita Ward, Kumamoto City) has started to develop a vaccine for a new coronavirus infection. At a press conference held on April 25, President Nagasato said, "Our strength lies in the fact that we have skilled technicians and facilities from our days at the Research Institute for Chemotherapy and Serotherapy (KAKETSUKEN). As a member of the Meiji Group, we will do our utmost to expand this business. The new drug will be developed jointly with the National Institute of Infectious Diseases, the Institute of Medical Science of the University of Tokyo, and the National Institute of Biomedical Innovation, Health and Nutrition. The company will consider using its Kikuchi Research Center in Kikuchi City, Kumamoto Prefecture, and its Koshi Plant in Koshi City, Kumamoto Prefecture, which are capable of producing vaccines for 57 million new influenza cases. (Photo taken on May 25, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)